Nintedanib is a drug that is used to treat idiopathic pulmonary fibrosis (IPF) and some types of interstitial lung disease (ILD). Nintedanib is a tyrosine kinase inhibitor (TKI), which blocks enzymes in cells in the lungs called tyrosine kinases. Blocking these enzymes helps decrease fibrous tissue forming in the lungs and so stops the symptoms of lung disease from getting worse.
ShareTweetShareWhatsAppEmail